Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.
3.

The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.

Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, Goldin R, Njai HF, Ndow G, Taal M, Cooke G, D'Alessandro U, Vray M, Mbaye PS, Njie R, Mallet V, Thursz M.

Gut. 2016 Aug;65(8):1369-76. doi: 10.1136/gutjnl-2015-309260. Epub 2015 Jun 24.

4.

Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.

Park YE, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Han S, Jeon MY, Heo JY, Song K, Kim SU.

J Gastroenterol Hepatol. 2017 Jun;32(6):1221-1229. doi: 10.1111/jgh.13653.

PMID:
27859587
5.

Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.

Liu DP, Lu W, Zhang ZQ, Wang YB, Ding RR, Zhou XL, Huang D, Li XF.

J Viral Hepat. 2018 May;25(5):581-589. doi: 10.1111/jvh.12842. Epub 2018 Jan 4.

PMID:
29230907
6.
8.

Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.

Hu YC, Liu H, Liu XY, Ma LN, Guan YH, Luo X, Ding XC.

World J Gastroenterol. 2017 Nov 7;23(41):7425-7432. doi: 10.3748/wjg.v23.i41.7425.

9.

Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China.

Ren T, Wang H, Wu R, Niu J.

Gastroenterol Res Pract. 2017;2017:7089702. doi: 10.1155/2017/7089702. Epub 2017 Jul 31.

10.
11.

The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.

Li Q, Lu C, Li W, Huang Y, Chen L.

J Viral Hepat. 2017 Dec;24(12):1143-1150. doi: 10.1111/jvh.12751. Epub 2017 Aug 7.

PMID:
28685907
12.

Comparison of non-invasive models for predicting liver damage in chronic hepatitis B patients.

Yu K, Du Z, Li Q, Cheng Q, Huang C, Shi G, Li N.

Gastroenterol Hepatol. 2019 May;42(5):281-288. doi: 10.1016/j.gastrohep.2018.12.004. Epub 2019 Feb 14. English, Spanish.

PMID:
30772087
13.

The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection.

Lee J, Kim MY, Kang SH, Kim J, Uh Y, Yoon KJ, Kim HS.

Br J Biomed Sci. 2018 Jul;75(3):128-132. doi: 10.1080/09674845.2018.1459147. Epub 2018 Jun 12.

PMID:
29893189
14.

Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.

Huang R, Wang G, Tian C, Liu Y, Jia B, Wang J, Yang Y, Li Y, Sun Z, Yan X, Xia J, Xiong Y, Song P, Zhang Z, Ding W, Wu C.

Sci Rep. 2017 Aug 17;7(1):8543. doi: 10.1038/s41598-017-09234-w.

15.

Diagnostic thresholds and performance of noninvasive fibrosis scores are limited by age in patients with chronic hepatitis B.

Wang W, Zhao X, Li G, Wang L, Chen Y, Ma K, Chen G, Chen T, Han M, Ning Q, Zhao X.

J Med Virol. 2019 Jul;91(7):1279-1287. doi: 10.1002/jmv.25435. Epub 2019 Mar 4.

PMID:
30788841
16.

Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.

Liu R, Guo J, Lu Y, Zhang L, Shen G, Wu S, Chang M, Hu L, Hao H, Li M, Xie Y.

Clin Exp Med. 2019 Aug;19(3):309-320. doi: 10.1007/s10238-019-00560-z. Epub 2019 May 20.

PMID:
31111345
17.

Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.

Li Q, Lu C, Li W, Huang Y, Chen L.

Clin Exp Med. 2018 Feb;18(1):71-78. doi: 10.1007/s10238-017-0472-3. Epub 2017 Sep 7.

PMID:
28884309
18.

Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.

Başar O, Yimaz B, Ekiz F, Giniş Z, Altinbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O.

Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):152-8. doi: 10.1016/j.clinre.2012.07.003. Epub 2013 Feb 4.

PMID:
23391746
19.

Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.

Wang RQ, Zhang QS, Zhao SX, Niu XM, Du JH, Du HJ, Nan YM.

J Int Med Res. 2016 Dec;44(6):1302-1313. doi: 10.1177/0300060516664638. Epub 2016 Nov 11.

20.

Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.

Song BG, Sinn DH, Chi S, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1447-1452. doi: 10.1097/MEG.0000000000001226.

PMID:
30063482

Supplemental Content

Support Center